Portfolio companies.
34,000+ PE-backed.

Active investments and exits across European private equity portfolios.
Filter by sector, geography, status. Find the right deal comp in seconds.

Active deals

241

currently held

Exits tracked

163

hand-checked

Sectors covered

across the portfolio

Countries covered

from every market

Latest activityLast event 2026-10-07

BP Technology VenturesadminDirector Departure · Resignation of MORELAND, Jennifer Lynne (director) · director resigned · governance change5 days ago

BP Technology Ventures5 days ago

Director Departure · Resignation of MORELAND, Jennifer Lynne (director) · director resigned · governance change

admin

B.P. Marsh & PartnerscapitalCapital Event · capital-return-purchase-own-shares-treasury-capital-date · Capital structure change5 days ago

B.P. Marsh & Partners5 days ago

Capital Event · capital-return-purchase-own-shares-treasury-capital-date · Capital structure change

capital

Arkea CapitaladminBoard change · Management board member change:: TRIDEAU Thomas, Jérôme · Change in the management board6 days ago

Arkea Capital6 days ago

Board change · Management board member change:: TRIDEAU Thomas, Jérôme · Change in the management board

admin

Caledonia InvestmentscapitalCapital Event · capital-cancellation-shares · Capital structure change6 days ago

Caledonia Investments6 days ago

Capital Event · capital-cancellation-shares · Capital structure change

capital

Cervinvest CapitaladminCEO change · Appointment of CEO De Jongh, Guillaume · New CEO appointed1 week ago

Cervinvest Capital1 week ago

CEO change · Appointment of CEO De Jongh, Guillaume · New CEO appointed

admin

Cervinvest CapitaladminChairman change · Appointment of Chairman Radix, Maxence. Departure of CEO Rouland, Antoine · New Chairman appointed. CEO departure · leadership transition underway1 week ago

Cervinvest Capital1 week ago

Chairman change · Appointment of Chairman Radix, Maxence. Departure of CEO Rouland, Antoine · New Chairman appointed. CEO departure · leadership transition underway

admin

Company	Sector	Geo	Investor	Entry	Hold	Status	Buyer	MOIC
Advantice Health TA XIV	Pharma	USA	TA Associates	–	–	Active	–	–
ADVICENNE IRDInov	Pharma	France	Irdi Capital-Investissement	2017	9yr	Active	–	–
Aileens Pharma Panakes Fund I	Pharma	Italy	Panakes Partners SGR	2018	8yr	Active	–	–
Alcami Corporation GHO Capital III LP	Pharma	USA	GHO Capital	2022	4yr	Active	–	–
Alfavet Aurica Search Fund I	Pharma	Germany	Aurica Capital Desarrollo	2024	2yr	Active	–	–
ALGIAX HTGF II	Pharma	Germany	High-Tech Gruenderfonds (HTGF)	2012	14yr	Active	–	–
Aliri MED III	Pharma	United States	ARCHIMED	2021	5yr	Active	–	–
Alvogen CVC Capital Partners Portfolio	Pharma	–	CVC Capital Partners	–	–	Active	–	–
Anovo Ardian Co-Investment Fund VI	Pharma	USA	Ardian	–	–	Active	–	–
Apurano Capmont Private Equity	Pharma	Germany	Capmont	2023	3yr	Active	–	–
Ardena GHO Capital Fund II LP	Pharma	Belgium	GHO Capital	2020	6yr	Active	–	–
Ascend Gene & Cell Therapies Cathay Health	Pharma	France	Cathay Capital	–	–	Active	–	–
AspiAir ATON Evergreen Holding	Pharma	Germany	ATON GmbH	2019	7yr	Active	–	–
Aston Particle Technologies DSW Ventures	Pharma	UK	DSW Venture Capital	2022	4yr	Active	–	–
Axience Motion Equity Partners Fund	Pharma	France	Motion Equity Partners	2024	2yr	Active	–	–
Axplora Europe VI (BE VI)	Pharma	Germany	Bridgepoint	2020	6yr	Active	–	–
BioDuro Latin American Private Equity Fund VII	Pharma	USA	Advent International	–	–	Active	–	–
Biofrontera AG Deutsche Balaton Evergreen Holding (Balance Sheet)	Pharma	Germany	Deutsche Balaton Aktiengesellschaft	2019	7yr	Active	–	–
Bioluz IDES (Institut de Développement de l’Economie Sociale)	Pharma	France	ESFIN GESTION	2013	13yr	Active	–	–
BMG Pharma Friulia Balance Sheet	Pharma	Italy	Friulia	2021	5yr	Active	–	–
Cambrex Permira VII	Pharma	USA	Permira	2019	7yr	Active	–	–
CANbridge General Atlantic	Pharma	China	General Atlantic	–	–	Active	–	–
CERES NIO II	Pharma	France	Naxicap Partners	2021	5yr	Active	–	–
Ceva Animal Health MED Rise	Pharma	France	ARCHIMED	2025	1yr	Active	–	–
Chanelle Pharma Exponent Private Equity Partners V	Pharma	Ireland	Exponent Private Equity	2024	2yr	Active	–	–
Cheplapharm CIC Debt Fund 4	Pharma	Germany	CIC Private Debt	2022	4yr	Active	–	–
CNX Therapeutics Inflexion Continuation Fund I	Pharma	UK	Inflexion	2025	1yr	Active	–	–
Cohance (formerly Suven) Latin American Private Equity Fund VII	Pharma	Mexico	Advent International	–	–	Active	–	–
Corealis MED Platform II	Pharma	Canada	ARCHIMED	2022	4yr	Active	–	–
CORXEL Leaps by Bayer	Pharma	China	Leaps by Bayer	2024	2yr	Active	–	–
CSO Pharmitalia Star III Private Equity Fund	Pharma	Italy	Star Capital SGR	2016	10yr	Active	–	–
Cuantum Medical Cosmetics Inveready Biotech II	Pharma	Spain	Inveready Asset Management	2015	11yr	Active	–	–
curia The Carlyle Group Portfolio	Pharma	USA	The Carlyle Group	–	–	Active	–	–
Demecan Holding GmbH Technologiefonds Hessen	Pharma	Germany	BMH Beteiligungsmanagement Hessen	2021	5yr	Active	–	–
Develco Pharma SHS V	Pharma	Switzerland	SHS Gesellschaft für Beteiligungsmanagement	2020	6yr	Active	–	–
Ergomed Permira VIII	Pharma	UK	Permira	2023	3yr	Active	–	–
Essential Pharma Penta Capital Fund I	Pharma	UK	Penta Capital	2025	1yr	Active	–	–
Farmalider MCH Iberian Capital Fund V	Pharma	Spain	MCH Private Equity Investments	2023	3yr	Active	–	–
Galenicum Peninsula Investments Europe	Pharma	France	Peninsula Capital	2021	5yr	Active	–	–
Grupo Farmaceutico Somar Latin American Private Equity Fund VII	Pharma	Mexico	Advent International	–	–	Active	–	–
H.A.C.Pharma Capital Santé 2	Pharma	France	Turenne Groupe	2022	4yr	Active	–	–
H2 Pharma Ardian Growth Fund II	Pharma	France	Ardian	2020	6yr	Active	–	–
Horus Pharma Nov Sante Actions Non Cotees	Pharma	France	Eurazeo	2022	4yr	Active	–	–
ICE Pharma Latin American Private Equity Fund VII	Pharma	Latin America	Advent International	–	–	Active	–	–
Ideal Cures Pvt. Ltd. TA Associates Portfolio	Pharma	India	TA Associates	–	–	Active	–	–
InnoSyn Mérieux Innovation 1	Pharma	Netherlands	Merieux Equity Partners	2023	3yr	Active	–	–
Interor Capital Santé 2	Pharma	France	Turenne Groupe	2020	6yr	Active	–	–
IRAB MED Rise	Pharma	Spain	ARCHIMED	2026	0yr	Active	–	–
Laboratoire Polidis Siparex Entrepreneurs 6	Pharma	France	Siparex	2025	1yr	Active	–	–
Laxxon Medical Evonik Venture Capital	Pharma	United States	Evonik Venture Capital	2022	4yr	Active	–	–

Portfolio companies.34,000+ PE-backed.

Portfolio companies.
34,000+ PE-backed.